Investical Earnings & investing calendar Earnings & investing calendar
/
PPharma Foods International Co.,Ltd. logo
2929TSE Prime

Pharma Foods International Co.,Ltd.

ファーマフーズ Yahoo Finance

Recent & upcoming events

Oct 27
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Sep 11
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Jul 29
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Jul 28
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Jun 10
Earnings 2:00
Q3 earnings announcement (scheduled)
Add to Google Calendar
Mar 13
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
2025
Dec 11
Earnings 1:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Dec 11
Est.
Earnings 1:00 approx.
Q1 earnings
Add to Google Calendar
2027
Jan 26
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Jan 27
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Mar 12
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
Jun 11
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar
Jul 27
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Jul 28
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Sep 17
Est.
Earnings 2:00 approx.
Earnings announcement (predicted)
Add to Google Calendar
Past events
2026
Oct 27
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar

KPI highlights

FY26
Revenue ¥63.22B YoY -3.1%
Operating income ¥2.63B margin 4.2%
Net income ¥1.99B YoY +440.2%
EPS ¥69 YoY +434.8%
P/E —
ROE 16.1% Equity ratio 38% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/07 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥64.00B +1.2%
Operating income ¥3.00B +14.0%
Net income ¥2.20B +10.7%
EPS ¥76 +10.4%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY24 Q3FY25 Q4
Revenue ¥16.04B¥16.14B¥15.51B¥15.52B¥14.98B—
Operating income ¥1.98B¥603M¥934M¥1.73B¥1.85B—
Net income ¥2.01B¥286M¥482M¥1.09B¥1.35B—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2025）

事業法人 14.8%国内機関 10.8%個人 15.9%未開示 58.5%20212022202320242025
事業法人国内機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 10.8%日本マスタートラスト信託銀行株式会社（信託口）金　武祚 7.7%金　武祚株式会社ＰＦホールディングス 5.1%株式会社ＰＦホールディングス伊藤忠商事株式会社 5%伊藤忠商事株式会社益田　和二行 2.6%益田　和二行江崎グリコ株式会社 2.5%江崎グリコ株式会社金　英一 2.3%金　英一ロート製薬株式会社 2.1%ロート製薬株式会社金　千尋 1.8%金　千尋益田　美玲 1.6%益田　美玲20212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
日本マスタートラスト信託銀行株式会社（信託口） 3,122,700 10.8% Yuho (EDINET)
金 武祚 2,227,334 7.7% Yuho (EDINET)
株式会社PFホールディングス 1,480,000 5.1% Yuho (EDINET)
伊藤忠商事株式会社 1,452,000 5.0% Yuho (EDINET)
益田 和二行 736,685 2.6% Yuho (EDINET)
江崎グリコ株式会社 732,000 2.5% Yuho (EDINET)
金 英一 672,006 2.3% Yuho (EDINET)
ロート製薬株式会社 600,000 2.1% Yuho (EDINET)
金 千尋 509,100 1.8% Yuho (EDINET)
益田 美玲 453,300 1.6% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

5/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 5.7%
✗ Positive operating cash flow ¥-1.18B
✓ ROA improved YoY 1.1% → 5.7%
✗ Operating CF exceeds net income (accrual quality) OCF ¥-1.18B / net income ¥1.99B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 35.4% → 37.5%
✓ Current ratio improved 1.19× → 1.26×
✓ No dilution (shares outstanding did not increase) 29,079,000 → 29,079,000
✗ Gross margin improved 80.6% → 80.2%
✗ Asset turnover improved 2.00× → 1.80×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 37.5%
Current ratio 1.3×
Years of positive operating CF 6 of last 11 yrs
Payout ratio —
Latest fiscal year result Profit (net income ¥1.99B)

Performance history

Last 10 years
0億円171億円343億円514億円686億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 47.279.4105154468602686621653632
Operating income 0.892.965.767.4056.710.836.151.123.726.3
Ordinary income 1.443.606.377.8957.712.635.452.525.524.4
Net income 1.013.145.006.9138.4-3.7430.832.13.6819.9
Total assets 58.463.387.3101209312362366326351
Equity 35.939.143.249.184.770.796.3116115132

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥3¥11¥17¥24¥132¥-13¥107¥113¥13¥69
ROE 2.9%8.4%12.2%15.0%57.5%-4.8%36.9%30.2%3.2%16.1%
Operating CF 2.344.160.91-5.4759.4-60.761.354.9-10.9-11.8
Investing CF -3.82-1.72-3.01-8.61-4.42-25.4-10.1-13.9-9.50-40.0
Financing CF 9.04-1.8215.93.7610.376.823.4-48.4-44.738.1
FCF -1.492.43-2.10-14.155.0-86.051.141.0-20.4-51.8

Source: EDINET (Annual Securities Report) (fetched 2026-10-23) *Some metrics supplemented from additional sources

Key financial metrics

High ROE ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data